FDA Approves Second Alzheimer’s Drug That Can Modestly Slow Disease
The Food and Drug Administration approved Eli Lilly’s Kisunla for mild or early cases of dementia caused by Alzheimer’s. …
FDA Approves Second Alzheimer’s Drug That Can Modestly Slow Disease Read More »









